Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care | JCO Oncology Practice
Climate change is like cancer, delayed action leads to more suffering for patients.
Related Articles
Paper: Impact of Clonal Heterogeneity in Newly Diagnosed, Transplant-Eligible Multiple Myeloma – Subgroup Analysis of the GMMG HD6 Phase III Trial
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Decluttering Responses and Dynamic Risk: How Can We Improve Prognostication in…
Origins and impact of extrachromosomal DNA
Nature – A study examines the diversity of extrachromosomal DNA elements in cancer, and provides details on the frequency and origin of extrachromosomal DNA and…
Chinmay Jani: Presenting collaborative project on HRR testing – OncoDaily
Chinmay Jani: Presenting collaborative project on HRR testing / cancer, Chinmay Jani, FLASCO, HRR testing guidelines, OncoDaily, Oncology, Pfizer Oncology,
Sample size for developing a prediction model with a binary…
When developing a clinical prediction model, the sample size of the development dataset is a key consideration. Small sample sizes lead to greater concerns of…
Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929
To evaluate whether the addition of a poly (ADP-ribose) polymerase inhibitor (PARPi) talazoparib to maintenance immune checkpoint inhibitor (ICI) atezolizumab following frontline chemoimmunotherapy improved outcomes…
Early morning and evening activity could ‘reduce bowel cancer risk by 11%’
Research suggests time when physical activity taken is crucial, opening way to targeted prevention strategies
A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
Peripheral T-cell lymphomas are rare and have poorer prognoses than more common B-cell lymphomas. It is therefore appropriate to highlight the current stat
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution
Nature – Whole-genome sequencing of matched serial tumours from patients identifies two key mutagenic factors (APOBEC3 and chemotherapy) and extrachromosomal DNA-forming structural variants that…
From Glucose Patterns to Health Outcomes: A Generalizable…
Recent advances in self-supervised learning enabled novel medical AI models, known as foundation models (FMs) that offer great potential for characterizing health from diverse biomedical…
The Evolutionary Forest of Pancreatic Cancer
Abstract. The genomic features of pancreatic ductal adenocarcinoma (PDAC) have been well described, yet the evolutionary contexts within which these features occur remain unexplored. We…
